Lmr Partners LLP Moderna, Inc. Put Options Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $27.9 Million - $46 Million	276,000 Added 1380.0%	296,000 $35.2 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $5.98 Million - $8.08 Million	-70,000 Reduced 77.78%	20,000 $2.13 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $3.93 Million - $5.9 Million	-56,500 Reduced 38.57%	90,000 $8.95 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $1.77 Million - $2.33 Million	18,400 Added 14.36%	146,500 $15.1 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $15.2 Million - $20.6 Million	128,100 New	128,100 $15.6 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.